FdaApplication
NDA 212535
Identifiers
- fda_app_no: NDA212535
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 2019-12-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NOURESS | CYSTEINE HYDROCHLORIDE | 500MG/10ML (50MG/ML) | SOLUTION;INTRAVENOUS |
1 product